St. Louis

Bayer's $100 Million Creve Coeur Shakeup Kicks Into High Gear

AI Assisted Icon
Published on February 26, 2026
Bayer's $100 Million Creve Coeur Shakeup Kicks Into High GearSource: Google Street View

Construction crews have quietly rolled onto Bayer's Creve Coeur campus, signaling that a long‑planned overhaul of the former Monsanto site is no longer just a PowerPoint slide. The company is moving ahead with a roughly $100 million renovation of its St. Louis‑area offices to modernize labs, conference rooms and workspaces. Local permit filings already show more than $15 million in active work, a clear signal the project has shifted from planning into construction as Bayer reshapes the campus and consolidates space for hybrid work.

According to the St. Louis Business Journal, building permits tied to the Creve Coeur property list multiple projects whose combined valuations exceed $15 million and indicate that contractors have already mobilized on site. The Business Journal's reporting is the clearest indication so far that Bayer's long‑announced investment has officially entered the build phase.

As outlined by Bayer, the company announced in August 2024 that it planned to invest more than $100 million into its St. Louis campuses while putting portions of the Creve Coeur property on the market. The plan calls for modern, collaborative office space along with new investment in labs and greenhouses that support its Crop Science operations.

The city of Creve Coeur is already rewriting its playbook to prepare for what comes next on parts of the site. Per the City of Creve Coeur, officials have launched a comprehensive‑plan update focused on the Bayer East parcel that will guide future redevelopment, complete with public meetings and a formal review process.

Permits Move The Project Into Construction

The permit filings cited by the Business Journal carry valuations that together top $15 million, a threshold that typically means a project has moved out of design and into execution. The St. Louis Business Journal reports that the permits cover multiple buildings on the Creve Coeur campus, hinting at a broad, campus‑wide refresh rather than a single‑building touch‑up.

Bayer Frames The Work As Modernizing The Campus

"We remain committed to the St. Louis region," Bayer said in its earlier announcement, casting the renovations as part of a long‑term bet on its local footprint. The company said the investments would create more collaborative, technology‑enabled workspaces and upgrade research infrastructure. In its announcement, Bayer also emphasized that the changes are meant to better integrate teams and support a hybrid model of work across its Crop Science operations.

How The Renovations Fit With Campus Sales

While pouring money into the core of the Creve Coeur campus, Bayer has simultaneously been paring off portions of the property for several years. The western side of the site was approved in 2023 for a large mixed‑use redevelopment. As reported by Spectrum News, the Olia Village plan would transform part of the former Bayer West campus into housing, retail and parks, a sharp contrast to the company's decision to invest heavily in the remaining core buildings it plans to keep.

Jobs And Neighborhood Impact

Bayer has been a major local employer since the Monsanto era, and the company’s presence has long been tied to regional job totals. When Bayer consolidated operations in St. Louis in 2019, state officials said the move would retain roughly 4,400 jobs and add about 500 positions. Local officials and business groups have said that updated office and lab space plays a role in keeping those high‑skill jobs anchored in the region.

What Happens Next

Upgrades on the scale of a full campus are rarely quick hits. Large renovations typically unfold over many months, with permit approvals, phased construction and contractor schedules all shaping the timeline. Residents and neighbors should expect more detailed announcements from both the company and the city as plans move forward. According to the City of Creve Coeur, the comprehensive‑plan update and its associated public hearings are the next formal steps for any new use of the Bayer parcels, while the freshly filed permits mark the start of physical work on the buildings Bayer intends to hold onto.